Episode Details
Back to Episodes
Episode 191 ESMO 2022: PROSPER study of neoadjuvant nivolumab in RCC
Season 1
Episode 191
Published 4 years, 1 month ago
Description
Mohamed Allaf describes the results of this study from ESMO.